US2021308677A1PendingUtilityA1

Systems and Methods for Mobile Device Analysis of Nucleic Acids and Proteins

Assignee: NANOBIOSYM INCPriority: Mar 15, 2013Filed: Jan 4, 2021Published: Oct 7, 2021
Est. expiryMar 15, 2033(~6.6 yrs left)· nominal 20-yr term from priority
Inventors:Anita Goel
B01L 2300/0645B01L 2400/0487B01L 2200/143B01L 2400/0478B01L 2300/1822B01L 2300/025B01L 2200/0689Y02A90/10B01L 2400/0622B01L 7/52B01L 3/502738B01L 2300/023B01L 3/502753G01N 27/44726B01L 2400/0672B01L 2300/0816B01L 2200/04B01L 2200/141B01L 2400/043
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

One aspect of the invention provides a system for rapid analysis of biological samples. The system includes: a mobile device that receives at least one integrated chip. The mobile device processes the integrated chip to analyze a biological sample loaded thereon. The mobile device and the integrated chip together are configured to perform at least one of manipulation and control of a molecule or a fluidic system on the integrated chip. The mobile device and integrated chip together are configured to precision control at least one parameter that governs at least one of a plurality of steps of the analysis of the biological sample to within plus or minus 10%, plus or minus 1%, plus or minus 0.1%, plus or minus 0.01%, plus or minus 0.001% or plus or minus 0.0001%.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A system for rapid analysis of biological samples, comprising:
 a mobile device that receives at least one integrated chip;   the mobile device processing the integrated chip to analyze a biological sample loaded thereon;   the mobile device and the integrated chip together being configured to perform at least one of manipulation and control of a molecule or a fluidic system on the integrated chip;   and wherein the mobile device and integrated chip together are configured to precision control at least one parameter that governs at least one of a plurality of steps of the analysis of the biological sample to within plus or minus 10%, plus or minus 1%, plus or minus 0.1%, plus or minus 0.01%, plus or minus 0.001% or plus or minus 0.0001%.

Join the waitlist — get patent alerts

Track US2021308677A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.